Literature DB >> 25183578

When can nutritional therapy impact liver disease?

Matthew C Bozeman1, Matthew V Benns, Stephen A McClave, Keith R Miller, Christopher M Jones.   

Abstract

This article reviews the current literature regarding nutritional therapy in liver disease, with an emphasis on patients progressing to liver failure as well as surgical patients. Mechanisms of malnutrition and sarcopenia in liver failure patients as well as nutritional assessment, nutritional requirements of this patient population, and goals and methods of therapy are discussed. Additionally, recommendations for feeding, micronutrient, branched chain amino acid supplementation, and the use of pre- and probiotics are included. The impact of these methods can have on patients with advanced disease and those undergoing surgical procedures will be emphasized.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25183578     DOI： 10.1007/s11894-014-0411-3

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


  69 in total

Review 1.  Probiotics for patients with hepatic encephalopathy.

Authors:  Richard G McGee; Anouk Bakens; Kerrie Wiley; Stephen M Riordan; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

2.  Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.

Authors:  Puneeta Tandon; Michael Ney; Ivana Irwin; Mang M Ma; Leah Gramlich; Vincent G Bain; Nina Esfandiari; Vickie Baracos; Aldo J Montano-Loza; Robert P Myers
Journal:  Liver Transpl       Date:  2012-10       Impact factor: 5.799

3.  Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).

Authors:  V J Canzanello; L Schwartz; S J Taler; S C Textor; R H Wiesner; M K Porayko; R A Krom
Journal:  Liver Transpl Surg       Date:  1997-01

4.  Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis.

Authors:  Luciana Carvalho; Edison Roberto Parise
Journal:  Arq Gastroenterol       Date:  2006 Oct-Dec

5.  ESPEN Guidelines on Enteral Nutrition: Liver disease.

Authors:  M Plauth; E Cabré; O Riggio; M Assis-Camilo; M Pirlich; J Kondrup; P Ferenci; E Holm; S Vom Dahl; M J Müller; W Nolte
Journal:  Clin Nutr       Date:  2006-05-16       Impact factor: 7.324

6.  Muscle wasting is associated with mortality in patients with cirrhosis.

Authors:  Aldo J Montano-Loza; Judith Meza-Junco; Carla M M Prado; Jessica R Lieffers; Vickie E Baracos; Vincent G Bain; Michael B Sawyer
Journal:  Clin Gastroenterol Hepatol       Date:  2011-09-03       Impact factor: 11.382

7.  The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study.

Authors:  Bret H Goodpaster; Seok Won Park; Tamara B Harris; Steven B Kritchevsky; Michael Nevitt; Ann V Schwartz; Eleanor M Simonsick; Frances A Tylavsky; Marjolein Visser; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-10       Impact factor: 6.053

8.  Increased protein catabolism without hypermetabolism after human orthotopic liver transplantation.

Authors:  R L Shanbhogue; B R Bistrian; R L Jenkins; S Randall; G L Blackburn
Journal:  Surgery       Date:  1987-02       Impact factor: 3.982

9.  Purification and properties of branched-chain alpha-keto acid dehydrogenase phosphatase from bovine kidney.

Authors:  Z Damuni; M L Merryfield; J S Humphreys; L J Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

Review 10.  Nutrition and chronic liver disease.

Authors:  Carla Matos; Michael K Porayko; Nickie Francisco-Ziller; Sara DiCecco
Journal:  J Clin Gastroenterol       Date:  2002 Nov-Dec       Impact factor: 3.062
View more
  1 in total

Review 1.  Can Nutritional Assessment Tools Predict Response to Nutritional Therapy?

Authors:  Chirag Patel; Endashaw Omer; Sarah J Diamond; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2016-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.